Dr Reddy’s ties up with US firm for resuscitative therapy – Times of India
[ad_1] NEW DELHI: Dr Reddy’s has entered into a licence agreement with Pharmazz, a US based biopharmaceutical company, to commercialise a first-in-class innovative drug Centhaquine in India.Developed by Pharmazz, Centhaquine is a resuscitative agent, presently indicated for the treatment of hypovolemic shock, by the Drugs Controller General of India (DCGI), says a company statement.As per…